New cancer drugs taking longer to reach NHS patients 04 Dec 2018 NHS patients are waiting longer for new cancer drugs because of delays in taking them through clinical trials and getting them approved for use, a major new analysis of regulatory data reveals. Find out more Show/Hide
ICR responds to NICE decision on olaparib for women with advanced ovarian cancer 09 Nov 2018 NICE has announced today, its decision not to recommend olaparib for women with advanced ovarian cancer who had previously responded to platinum chemotherapy for six months or longer. Find out more Show/Hide
Climb of Life fundraising total hits £1 million 07 Nov 2018 In its 12th year raising money for The Institute of Cancer Research, London, the Climb of Life has reached the tremendous milestone of raising over £1 million. Find out more Show/Hide
The ICR responds to decision by NICE not to recommend abiraterone as first-line treatment for advanced prostate cancer 06 Jun 2018
New resource to challenge widespread poor practice in biomedical researchers’ use of chemical probes 12 Dec 2017
European Medicines Agency approves abiraterone combined with hormone therapy as first-line treatment for advanced prostate cancer 22 Nov 2017
ICR fundraisers take part in Climb of Life 30th year celebrations to raise a new record-breaking total 21 Nov 2017